Anas Gazzah
0000-0002-6866-6787
Publication & Citation Trends
Publications
0 total
Tumor flare reactions secondary to T-cell engaging immunotherapies: A study from the French REISAMIC registry.
Cited by 0
Semantic Scholar
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Cited by 3
Semantic Scholar
Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry.
Cited by 0
Semantic Scholar
Abstract 4559: Paired liquid biopsies analysis reveals resistance mechanisms and prognostic factors in patients treated with KRASG12C inhibitors
Cited by 0
Semantic Scholar
Infectious events in patients treated for malignancies with T-cell engagers immunotherapies, a cohort study from the French REISAMIC registry.
Cited by 0
Semantic Scholar
Trial in progress: First-in-human study of PFL-721/STX-721 in participants with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion mutations.
Cited by 0
Semantic Scholar
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer.
Cited by 0
Semantic Scholar
Abstract CT089: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal bulk and single-cell RNAseq analyses of patient tumors identify biological correlates of response to PARP inhibitors and anti-PD-L1 therapy
Cited by 1
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(117)
Cancer Genomics and Diagnostics
(72)
Cancer Immunotherapy and Biomarkers
(66)
Occupational and environmental lung diseases
(60)
Pleural and Pulmonary Diseases
(44)
Affiliations
Université Paris-Sud
Inserm
Université Paris-Saclay
Institut Gustave Roussy
Institut de Recherche contre les Cancers de l’Appareil Digestif